thiethylperazine / Immungenetics - LARVOL DELTA

Thiethylperazine Reduces Phosphorylated Tau in Alzheimer's Disease: Confirming iN-based Results with Clinical Trial Data (CTAD 2025) - No abstract available

Clinical • Alzheimer's Disease • CNS Disorders

Tick-borne Encephalitis and Borrelial Antibodies in Serum (clinicaltrials.gov) - P=N/A | N=80 | Recruiting | Sponsor: University Medical Centre Ljubljana | Trial completion date: Dec 2021 ➔ Dec 2023 | Trial primary completion date: Dec 2021 ➔ Dec 2023

Trial completion date • Trial primary completion date • CNS Disorders • Lyme Disease